Wellington Management Group’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,847,443
Closed -$18.5M 2285
2021
Q4
$18.5M Sell
1,847,443
-76,316
-4% -$782K ﹤0.01% 1097
2021
Q3
$19.6M Sell
1,923,759
-565
-0% -$5.69K ﹤0.01% 1097
2021
Q2
$19.3M Sell
1,924,324
-40,425
-2% -$409K ﹤0.01% 1104
2021
Q1
$19.7M Buy
1,964,749
+10,184
+0.5% +$108K ﹤0.01% 1078
2020
Q4
$20.5M Buy
+1,954,565
New +$20.4M ﹤0.01% 1028

Other funds holding MTACU

Wellington Management Group's MTACU Position: Q1 2022 in Review

Wellington Management Group sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2022, closing a stake of 1,847,443 shares — an estimated $18.5M sold.

Wellington Management Group first reported a position in MTACU in Q4 2020 and held it in 5 quarters. The position peaked at $20.5M in Q4 2020. 5 funds tracked by Wall St. Rank hold MTACU as of Q1 2022.

  • Wellington Management Group reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
  • Wellington Management Group sold 1,847,443 MedTech Acquisition Corporation Unit shares in Q1 2022, an estimated $18.5M.
  • Wellington Management Group first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 5 quarters.
  • Wellington Management Group's MedTech Acquisition Corporation Unit position peaked at $20.5M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2022.

Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.